Heterozygous Carriers of Gitelman Syndrome

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Heterozygous Carriers of Gitelman Syndrome trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedNot Applicable

NCT02035046

Clinical Significance of Heterozygosity for Mutations of the SLC12A3 Gene Coding for the Thiazide Sensitive Na-Cl Cotran…

Gitelman syndrome is a salt wasting tubulopathy caused by mutations in the SLC12A3 gene coding for the thiazide sensitive sodium chloride cotransporter. This di…

France250 participantsStarted 2013-12

Treatment: Samplings of blood, Sampling of urine